image
Coherus BioSciences, Inc. CHRS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.744
-3.7 %
$ 85.7 M
Market Cap
-8.27
P/E
INCOME STATEMENT
257 M REVENUE
21.89%
Growth Rates
1Year 21.89%
3Years -18.54%
5Years 177.76%
7Years 4.42%
10Years 57.43%
-203 M OPERATING INCOME
20.90%
Growth Rates
1Year 20.90%
3Years -32.00%
5Years 0.12%
7Years -8.35%
10Years -18.90%
-238 M NET INCOME
18.46%
Growth Rates
1Year 18.46%
3Years -40.93%
5Years -2.58%
7Years -9.28%
10Years -16.06%
EFFICIENCY
Earnings Waterfall Coherus BioSciences, Inc.
image
Revenue 257 M
Cost Of Revenue 163 M
Gross Profit 94.5 M
Operating Expenses 301 M
Operating Income -203 M
Other Expenses 34.7 M
Net Income -238 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012
REVENUE
Revenue 257.2 211.0 326.6 475.8 356.1 1.6 1.6 190.1 30.0 31.1 2.8 1.9
GROSS PROFIT
Cost Of Revenue 162.8 70.1 57.6 37.7 17.1 3.2 160.5 254.4 212.7 78.2 31.3 34.9
Gross Profit 94.5 141.0 269.0 438.2 339.0 (1.7) (159.0) (64.3) (182.6) (47.1) (28.5) (33.0)
OPERATING INCOME
Operating Expenses 301.5 397.8 532.8 281.8 231.2 204.4 233.7 306.0 249.1 95.8 38.7 40.4
Selling, General and Administrative Expenses 185.6 198.5 169.7 139.1 137.0 94.2 71.3 51.6 36.0 17.6 7.5 5.5
Research and Development Expenses 109.4 199.4 363.1 142.8 94.2 110.2 162.4 254.4 213.1 78.2 31.3 34.9
Operating Income (203.2) (256.9) (263.9) 156.3 107.8 (204.4) (232.1) (115.9) (219.1) (64.7) (36.0) (38.5)
PRE-TAX INCOME
Interest Income Expense 40.5 32.5 23.0 21.2 17.6 9.7 9.6 8.0 33 K 3.9 5.3 1.5
Total Other Income (35.1) (34.9) (23.2) (20.6) (15.0) (5.0) (6.2) (11.9) (4.9) (22.5) (17.6) 5.5
Pre-Tax Income (238.3) (291.8) (287.1) 135.7 92.8 (209.4) (238.3) (127.8) (223.9) (87.2) (53.6) (33.0)
NET INCOME
Tax Provision (0.4) 34.9 19.2 3.5 2.9 4.7 9.4 0.7 (7.4) (15.4) (7.1) 8.5
Net Income (237.9) (326.6) (306.3) 132.2 89.8 (209.3) (238.2) (127.3) (223.3) (87.1) (53.6) (33.0)
EPS 2.53 4.21 4.06 1.85 1.29 3.22 4.48 3.04 6.01 10.6 2.97 1.83